![](/img/cover-not-exists.png)
Superior Long-Term Efficacy of Bortezomib Combined With High Dose IVIG in Contrast to Rituximab Based Antibody-Mediated Rejection Therapy in Renal Transplant Patients - A Comparative Retrospective Analysis.
Duerr, M., Lachmann, N., Neumayer, H., Budde, K., Waiser, J.Volume:
98
Journal:
Transplantation
DOI:
10.1097/00007890-201407151-00428
Date:
July, 2014
File:
PDF, 237 KB
2014